<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW, NOARCHIVE">
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<title>Giroux v. Trillium Health Centre and Harvey (January 27, 2005)</title>
<style><!--
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:553679495 -2147483648 8 0 66047 0;}
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	mso-pagination:widow-orphan;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:15.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-next:Normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";}
h3
	{mso-style-next:Normal;
	text-align:right;
	text-indent:-1.0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:-1.0in -.5in .05pt 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in 7.0in 7.5in 8.0in 8.5in 9.0in 9.5in 10.0in 10.5in 11.0in 11.5in 12.0in 12.5in 13.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
h5
	{mso-style-next:Normal;
	text-align:center;
	text-indent:-1.0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	tab-stops:-1.0in -.5in .05pt 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in 7.0in 7.5in 8.0in 8.5in 9.0in 9.5in 10.0in 10.5in 11.0in 11.5in 12.0in 12.5in 13.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
span.MsoFootnoteReference
	{vertical-align:super;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-pagination:widow-orphan;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-pagination:widow-orphan;
	background:navy;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.headingtitle, li.headingtitle, div.headingtitle
	{mso-style-name:"heading\: title";
	mso-style-update:auto;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in lined 3.0in blank 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingNUMBER, li.headingNUMBER, div.headingNUMBER
	{mso-style-name:"heading\: NUMBER";
	mso-style-update:auto;
	text-align:justify;
	text-indent:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo23;
	tab-stops:list .25in left .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingsubtitle, li.headingsubtitle, div.headingsubtitle
	{mso-style-name:"heading\: subtitle";
	mso-style-update:auto;
	text-indent:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:4;
	mso-list:l4 level4 lfo21;
	tab-stops:0in .5in list 1.25in left 1.5in 2.0in 2.5in lined 3.0in blank 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingsubsubtitle, li.headingsubsubtitle, div.headingsubsubtitle
	{mso-style-name:"heading\: subsubtitle";
	text-indent:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:5;
	mso-list:l4 level5 lfo21;
	tab-stops:0in .5in 1.0in list 1.25in left 1.5in 2.0in 2.5in lined 3.0in blank 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingQUOTE, li.headingQUOTE, div.headingQUOTE
	{mso-style-name:"heading\: QUOTE";
	mso-pagination:widow-orphan;
	tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in lined 3.0in blank 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingblank, li.headingblank, div.headingblank
	{mso-style-name:"heading\: blank";
	mso-style-update:auto;
	text-indent:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	mso-list:l4 level7 lfo21;
	tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in lined 3.0in blank 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.heading3subtitle, li.heading3subtitle, div.heading3subtitle
	{mso-style-name:"heading\: 3subtitle";
	text-indent:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:6;
	mso-list:l4 level6 lfo21;
	tab-stops:list 1.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-pagination:widow-orphan;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
@page Section1
	{size:8.5in 11.0in;
	mso-header-
	mso-footer-
	mso-title-page:yes;
	mso-header: url() h1;
	mso-paper-source:2;}
div.Section1
	{page:Section1;}
@list l0
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:1265521074;}
@list l0:level1
	{mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1
	{mso-list-id:181289697;
	mso-list-type:hybrid;
	mso-list-template-ids:-102090622 1515497508 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l1:level1
	{mso-level-start-at:2;
	mso-level-text:"\(%1\)";
	mso-level-tab-stop:93.75pt;
	mso-level-number-position:left;
	text-indent:-21.75pt;}
@list l2
	{mso-list-id:248387907;
	mso-list-template-ids:-853636652;}
@list l2:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level2
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l2:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l2:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l3
	{mso-list-id:388502664;
	mso-list-type:simple;
	mso-list-template-ids:-1467875128;}
@list l3:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-3.5in;
	font-family:Symbol;}
@list l4
	{mso-list-id:527061025;
	mso-list-template-ids:78953320;}
@list l4:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level4
	{mso-level-reset-level:level1;
	mso-level-style-link:"heading\: subtitle";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-style-link:"heading\: subsubtitle";
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-style-link:"heading\: 3subtitle";
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level7
	{mso-level-number-format:none;
	mso-level-style-link:"heading\: blank";
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l4:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5
	{mso-list-id:764231896;
	mso-list-template-ids:1352008676;}
@list l5:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level2
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level3
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"%3\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l5:level4
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level5
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level6
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l5:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l6
	{mso-list-id:798916144;
	mso-list-type:simple;
	mso-list-template-ids:1423321962;}
@list l6:level1
	{mso-level-style-link:"heading\: NUMBER";
	mso-level-text:"\[%1\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-size:13.0pt;
	font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;
	text-decoration:none;
	text-underline:none;}
@list l7
	{mso-list-id:911693226;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l7:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l8
	{mso-list-id:1250120100;
	mso-list-template-ids:-2020592624;
	mso-list-name:QUOTE;}
@list l8:level1
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level2
	{mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level3
	{mso-level-number-format:none;
	mso-level-text:%3;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level4
	{mso-level-suffix:none;
	mso-level-text:"\(%4\)\0009";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l8:level5
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%5\)\0009";
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l8:level6
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l8:level7
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l8:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l8:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l9
	{mso-list-id:1315601249;
	mso-list-type:simple;
	mso-list-template-ids:-52672024;}
@list l9:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l10
	{mso-list-id:1383941449;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l10:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l11
	{mso-list-id:1550385919;
	mso-list-template-ids:821708086;}
@list l11:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12
	{mso-list-id:1665664019;
	mso-list-template-ids:-1754337048;}
@list l12:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13
	{mso-list-id:1682200304;
	mso-list-template-ids:426402662;}
@list l13:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l13:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14
	{mso-list-id:1782457026;
	mso-list-type:simple;
	mso-list-template-ids:1131831968;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15
	{mso-list-id:1816682448;
	mso-list-template-ids:-784801062;}
@list l15:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l15:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level3
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-text:"%3\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l15:level4
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level5
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level6
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16
	{mso-list-id:1969626097;
	mso-list-type:hybrid;
	mso-list-template-ids:1418515476 891480346 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l17
	{mso-list-id:2059817004;
	mso-list-template-ids:-1213419456;}
@list l17:level1
	{mso-level-number-format:none;
	mso-level-style-link:"heading\: subtitle";
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
ol
	{ul
	{-->
</style>
</head>
<body lang=EN-CA style='tab-interval:.5in' bgcolor="#FFFFFF">
<div class=Section1> 
  <h3>DATE: 20050127<br>
    <span
style='mso-tab-count:1'>                        </span><b style='mso-bidi-font-weight:
normal'>DOCKET: C41422</b></h3>
  <h5><span style='font-size:15.0pt;mso-bidi-font-size:10.0pt'>COURT OF APPEAL 
    FOR ONTARIO</span></h5>
  <p class=MsoNormal align=center style='text-align:center'><b>ROSENBERG, MOLDAVER 
    and SIMMONS JJ.A.</b></p>
  <table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0in 5.4pt 0in 5.4pt' align="center">
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>BETWEEN:</b></p>
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b>JEAN GIROUX, Executor and Trustee for THE ESTATE 
          OF JAMES GIROUX, deceased, JEAN GIROUX personally, GARY GIROUX personally, 
          CATHY CREIGHTON personally, MICHAEL CREIGHTON, CHRISTOPHER GIROUX by 
          his Litigation Guardian Gary Giroux, JESSICA GIROUX by her Litigation 
          Guardian Gary Giroux, and ROBERT CREIGHTON by his Litigation Guardian 
          Cathy Creighton</b></p>
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal align=right style='text-align:right'><b>Plaintiffs 
          (Respondents)</b></p>
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal align=right style='text-align:right'>&nbsp;</p>
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b><span style='mso-tab-count:1'>            </span></b></p>
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b>- and -</b></p>
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b>TRILLIUM HEALTH CENTRE and <u>WILLIAM HARVEY</u></b></p>
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal align=right style='text-align:right'><b>Defendants 
          (Appellant)</b></p>
      </td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp;</td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'><b>J. 
        Thomas Curry and Matthew P. Sammon for the appellanWilliam Harvey</b></td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp;</td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'><b>Sandra 
        Barton for the respondents</b></td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp;</td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'><b>Heard:<span
  style="mso-spacerun: yes">  </span>November 29, 2004</b> </td>
    </tr>
  </table>
  <p class=MsoHeader><b
style='mso-bidi-font-weight:normal'>On appeal from the judgment of Justice Sidney 
    N. Lederman of the Superior Court of Justice dated February 12, 2004.</b></p>
  <p class=MsoHeader><b style='mso-bidi-font-weight:normal'>MOLDAVER J.A.:</b></p>
  <p class=MsoHeader style='page-break-after:avoid;
'><b style='mso-bidi-font-weight:normal'>INTRODUCTION</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [1]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>This appeal has its genesis in a medical 
    malpractice action brought by the estate of the late James Giroux against 
    Dr. William Harvey. In a nutshell, the estate claims that Dr.&nbsp;Harvey 
    was negligent in failing to diagnose and appropriately treat a malignant tumour 
    that formed in Mr. Giroux’s bladder and eventually claimed his life.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [2]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>Although Mr. Giroux passed away on November 
    28, 1999, his estate did not issue a statement of claim against Dr. Harvey 
    until June 23, 2003, some three and a half years later. (The claim was subsequently 
    amended on September 22, 2003).</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [3]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>In December 2003, Dr. Harvey moved under 
    Rule 21.01(1) of the <i>Rules of Civil Procedure</i><a style='mso-footnote-id:
ftn1' href="#_ftn1" name="_ftnref1" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [1] </span></span></a> for an order striking 
    out the amended claim and dismissing the action. He maintained that the action 
    was statute-barred because it had not been commenced within the two-year limitation 
    period prescribed by s. 38(3) of the <i>Trustee Act</i><a style='mso-footnote-id:ftn2' href="#_ftn2" name="_ftnref2" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [2] </span></span></a> 
    (the “Act). </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [4]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>Lederman J. heard the motion on January 9, 
    2004<a style='mso-footnote-id:ftn3' href="#_ftn3" name="_ftnref3" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [3] </span></span></a> 
    and, in written reasons released on February 12, 2004, he dismissed it. In 
    doing so, he found that the common law doctrine of fraudulent concealment 
    could be used to toll (suspend the running of the limitation clock) the limitation 
    period specified in s. 38(3) of the Act and that on the facts as pleaded, 
    the estate could rely upon the doctrine to resist Dr. Harvey’s motion. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [5]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>Dr. Harvey appeals from that ruling. He submits 
    that the doctrine of fraudulent concealment has no application to s. 38(3) 
    of the Act and that Lederman J. erred in holding otherwise. Alternatively, 
    he contends that if the doctrine is available, Lederman&nbsp;J. erred in concluding 
    that the facts as pleaded were capable of supporting it.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [6]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>With respect, I would not give effect to 
    either of those submissions. For reasons that follow, I am satisfied that 
    Lederman J. was correct in dismissing the motion and in allowing the action 
    to proceed. Accordingly, I would uphold his order and dismiss the appeal.</p>
  <h2>THE PERTINENT FACTS AS PLEADED BY THE RESPONDENTS</h2>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [7]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>As already noted, the appellant moved under 
    Rule 21.01 to have the amended claim struck out and the action dismissed. 
    On a motion of that nature, the facts as pleaded are assumed to be true. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [8]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>The pertinent facts as pleaded by the respondents 
    are reviewed in some detail in Lederman J.’s clear and comprehensive reasons. 
    They are contained in the amended statement of claim and two pieces of correspondence 
    incorporated by reference into it, namely: (1) a letter dated July&nbsp;1, 
    2001 from Mr.&nbsp;Giroux’s son to the Chief Executive Officer of the Trillium 
    Health Centre (the Centre where Dr.&nbsp;Harvey treated Mr. Giroux); and (2) 
    the Centre’s letter of response dated August 28, 2001.<a style='mso-footnote-id:ftn4' href="#_ftn4"
name="_ftnref4" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [4] </span></span></a><span
style="mso-spacerun: yes">  </span>The summary that follows is derived from those 
    documents.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [9]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span> <span
style='mso-tab-count:1'>      </span>Dr. Harvey is a specialist in urology. In 
    September 1998, he began treating Mr.&nbsp;James Giroux (the deceased) for 
    complications arising from the removal of a tumour on his bladder. Over the 
    next fourteen months, Mr. Giroux consulted with Dr. Harvey about his condition 
    on approximately 23 occasions. In that time frame, although Dr.&nbsp;Harvey 
    performed at least six cystosopies<a style='mso-footnote-id:ftn5' href="#_ftn5"
name="_ftnref5" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [5] </span></span></a> on Mr. Giroux, 
    he did not advise Mr.&nbsp;Giroux that his condition was life-threatening 
    and that the disease was likely to spread; nor did he recommend (or even discuss) 
    radical treatment such as radiation or the removal of the bladder.</p>
  <p class=headingNUMBER align=left style='
text-align:left;line-height:
normal'> [10]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In October 1999, while Dr. Harvey was away on vacation and Mr Giroux 
    was being treated by another doctor, Mr. Giroux was told for the first time 
    that the tumour on his bladder had grown and that he was suffering from high-grade 
    invasive cancer. By then however, it was too late to engage in radical treatment. 
    Nothing could be done to save Mr. Giroux. A month and a half later, on November 
    28, 1999, he died. He was seventy-six years old.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [11]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Following Mr. Giroux’s death, his family harboured concerns about 
    the treatment he had received from Dr. Harvey. In particular, they wanted 
    to know why Dr.&nbsp;Harvey had not diagnosed the nature of the cancer and 
    why he had not recommended radical treatment for it. To that end, on July 
    1, 2001 (nineteen months after Mr. Giroux’s death but five months before the 
    expiry of the two-year limitation period under s. 38(3) of the Act), Gary 
    Giroux, the deceased’s son, wrote to the Chief Executive Officer at Trillium 
    Health Centre seeking answers to these questions. Two months later, he received 
    a response that shocked and confused the family, particularly his mother. 
    In a letter dated August 28, 2001, under the signature of Dr. N. S. Hill, 
    acting Chief of Staff at Trillium, Dr. Hill reported that he had spoken to 
    Dr. Harvey about the questions raised in Mr.&nbsp;Giroux’s letter and that 
    Dr. Harvey had responded as follows:</p>
  <p class=MsoNormal style='mso-list:l16 level1 lfo24;
'> <span style='font-size:10.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> That by the end of September 1998, he (Dr. Harvey) had in fact 
    diagnosed the nature of Mr. Giroux’s cancer and the risks associated with 
    it.</p>
  <p class=MsoNormal style='mso-list:l16 level1 lfo24;
'> <span style='font-size:10.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> That he had discussed his diagnosis with Mr. and Mrs. Giroux 
    at that time.</p>
  <p class=MsoNormal style='mso-list:l16 level1 lfo24;
'> <span style='font-size:10.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> That Mr. Giroux<span style="mso-spacerun: yes">  </span>had 
    declined radical surgery or radiation.</p>
  <p class=MsoNormal style='mso-list:l16 level1 lfo24;
'> <span style='font-size:10.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> That on several occasions throughout the course of Mr. Giroux’s 
    treatment and as late as June 1999, he had again discussed with Mr. Giroux 
    the nature of the cancer and the risk that it would spread and in each instance, 
    Mr.&nbsp;Giroux had refused to consider more radical surgery or radiation.</p>
  <p class=MsoNormal style='mso-list:l16 level1 lfo24;
'> <span style='font-size:10.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> That in pursuing the course of treatment he adopted, he was 
    merely following Mr. Giroux’s wishes.</p>
  <p class=MsoNormal style='mso-list:l16 level1 lfo24;
'> <span style='font-size:10.0pt;
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> That with Mr. Giroux’s passing, he did not know whether Mrs. 
    Giroux would or would not be able to confirm that Mr. Giroux had declined 
    radiation and radical surgery early on in the course of his illness.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [12]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As indicated, Dr. Harvey’s response (transmitted through Dr. Hill) 
    shocked and confused Mrs. Giroux. She had accompanied her husband on every 
    visit to Dr. Harvey and Dr. Harvey had never discussed the possibility of, 
    or need for radical treatment. In view of that, the family requested a meeting 
    with Dr. Hill to discuss the matter further. By now, the two-year limitation 
    period under s. 38(3) of the Act was set to expire in three months.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [13]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The meeting with Dr. Hill took place on December 7, 2001 (about a 
    week after the expiry of the two-year limitation period). It proved valueless 
    because Dr. Hill could not answer the Girouxs’ questions. Accordingly, Dr. 
    Hill suggested that the family speak directly to Dr. Harvey. To that end, 
    a meeting was arranged at the end of January 2002. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [14]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At the January meeting, Dr. Harvey stated that he had left Mr. Giroux’s 
    medical file at his private office. Accordingly, another meeting was scheduled 
    for February 4, 2002.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [15]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> At the February 4<sup>th</sup> meeting, Dr. Harvey reiterated the 
    position that he had taken with Dr. Hill in August 2001. Specifically, he 
    advised the family that he had informed Mr. Giroux about the nature of his 
    illness and that he had recommended radical intervention (albeit to no avail) 
    in September and November 1998 and in May 1999. He further stated that he 
    had notes to that effect in Mr. Giroux’s medical file which he kept at his 
    office. Despite the family’s request that he produce the notes, he refused 
    to do so.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [16]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In the face of Dr. Harvey’s answers and his refusal to produce the 
    notes, the family felt that they still did not have a proper understanding 
    of the nature of Mr.&nbsp;Giroux’s illness and the treatment he had received. 
    Accordingly, on April 19, 2002, they wrote to the College of Physicians and 
    Surgeons seeking an independent review and assessment of the treatment provided 
    by Dr. Harvey to Mr. Giroux.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [17]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In March 2003, the family received the College’s response. It was 
    then, for the first time, that they appreciated that Dr. Harvey had deceived 
    them and that his representations to them had been false. Specifically, they 
    learned that he had never recommended radical treatment and that he had created 
    a false set of notes to cover his tracks.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [18]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Within three months of learning of Dr. Harvey’s misrepresentations 
    (the first of which occurred in Dr. Hill’s letter of August 28, 2001, when 
    three months remained on the limitation clock), the family issued a statement 
    of claim against him alleging medical malpractice. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [19]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Against that backdrop, I turn to the two issues raised on appeal. 
  </p>
  <p class=MsoBodyText style='
'>Issue One: Can the common law doctrine of fraudulent concealment be used to 
    toll the limitation period prescribed by s. 38(3) of the Act.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [20]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Section 38 of the <i>Trustee Act</i> reads as follows:</p>
  <p class=headingQUOTE>38(1)<span style="mso-spacerun: yes">  </span>Except in 
    cases of libel and slander, the executor or administrator of any deceased 
    person may maintain an action for all torts or injuries to the person or to 
    the property of the deceased in the same manner and with the same rights and 
    remedies as the deceased would, if living, have been entitled to do, and the 
    damages when recovered shall form part of the personal estate of the deceased 
    but if death results from such injuries no damages shall be allowed for the 
    death or for the loss of the expectation of life, but this proviso is not 
    in derogation of any rights conferred by Part V of the <i>Family Law Act</i>.</p>
  <p class=headingQUOTE style='mso-list:l1 level1 lfo25;
'> (2)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span> Except in cases 
    of libel and slander, if a deceased person committed or is by law liable for 
    a wrong to another in respect of his or her person or to another person’s 
    property, the person wronged may maintain an action against the executor or 
    administrator of the person who committed or is by law liable for the wrong.</p>
  <p class=headingQUOTE style='mso-list:l1 level1 lfo25;
'> (3)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span> <i>An action under 
    this section shall not be brought after the expiration of two years from the 
    death of the deceased</i> (emphasis added).</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [21]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Notably, under s. 38(3), the limitation period is tied to the date 
    of death, not the date upon which the claim is discovered. Dr. Harvey relies 
    heavily on that feature of the provision. More will be said about it shortly.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [22]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Fraudulent concealment has been defined to include “conduct, which, 
    having regard to some special relationship between the two parties concerned, 
    is an unconscionable thing for one to do towards the other”. (<i>Kitchen v. 
    Royal Air Force Association</i>, [1958] 2 All E.R. 241 (C.A.) per Lord Evershed 
    M.R. at p. 249, cited with approval in <i>M. (K.) v. M. (H.),</i> [1992] 3 
    S.C.R. 6 at para. 63. See also, <i>Guerin v. The Queen</i>, [1984] 2 S.C.R. 
    335). </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [23]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Applying that definition to this case, Dr. Harvey does not (for appeal 
    purposes) contest the “special” nature of his relationship with the Giroux 
    family; nor does he deny that his duplicitous conduct would, if proved, constitute 
    an unconscionable thing for him to do towards the family. His challenge is 
    more fundamental. He contends that the doctrine of fraudulent concealment 
    has no application because the two-year limitation period under s. 38(3) is 
    immutably tied to the date of death. Accordingly, it is immune to any and 
    all common law doctrines that might otherwise be used to extend or toll it. 
  </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [24]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In support of his position, Dr. Harvey relies primarily on this court’s 
    decision in <i>Waschkowski v. Hopkinson Estate</i>, [2000] 47 O.R. (3d) 370, 
    in which Abella&nbsp;J.A., for the court, held that the common law “discoverability” 
    rule does not apply to s. 38(3) of the Act. In so concluding, Abella J.A. 
    was careful to point out that the discoverability rule is nothing more than 
    a rule of construction and that its applicability depends on the wording of 
    the limitation provision. Accordingly, as she observed, the rule does not 
    apply when, based on the wording of the provision, “the limiting time runs 
    from a fixed event unrelated to the injured party’s knowledge or the basis 
    of the cause of action” (para. 7, citations omitted). Applying those principles 
    to s. 38(3) of the Act, Abella J.A. concluded at para. 8 as follows:</p>
  <p class=headingQUOTE>In s. 38(3) of the Trustee Act, the limitation period 
    runs from a death.<span style="mso-spacerun: yes">  </span>Unlike cases where 
    the wording of the limitation period permits the time to run, for example, 
    from “when the damage was sustained” (<i>Peixeiro</i>) [<i>Peixeiro v. Haberman</i>, 
    [1997] 3 S.C.R. 549] or when the cause of action arose (<i>Kamloops</i>) [<i>Kamloops 
    (City) v. Nielsen</i>, [1984] 2 S.C.R. 2], there is no temporal elasticity 
    possible when the pivotal event is the date of a death.<span
style="mso-spacerun: yes">  </span>Regardless of when the injuries occurred or 
    matured into an actionable wrong, s. 38(3) of the Trustee Act prevents their 
    transformation into a legal claim unless that claim is brought within two 
    years of the death of the wrongdoer or the person wronged.</p>
  <p class=headingNUMBER align=left style='
text-align:left;
line-height:normal'> [25]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Abella J.A. then considered whether that interpretation of s. 38(3) 
    accorded with the policy considerations underlying the implementation of s. 
    38 of the Act. In concluding that it did, she stated at para. 9:</p>
  <p class=headingQUOTE>The underlying policy considerations of this clear time 
    limit are not difficult to understand.<span style="mso-spacerun: yes">  </span>The 
    draconian legal impact of the common law was that death terminated any possible 
    redress for negligent conduct.<span style="mso-spacerun: yes">  </span>On 
    the other hand, there was a benefit to disposing of estate matters with finality.<span style="mso-spacerun: yes">  
    </span>The legislative compromise in s. 38 of the Trustee Act was to open 
    a two-year window, making access to a remedy available for a limited time 
    without creating indefinite fiscal vulnerability for an estate.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [26]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As indicated, Dr. Harvey relies heavily on the <i>Waschkowski</i> 
    decision. He submits that Abella J.A.’s analysis applies with equal force 
    to the common law doctrine of fraudulent concealment and that absent a statutory 
    exemption, all claims brought under s.&nbsp;38 of the Act must be instituted 
    within two years of the death of the wrongdoer or the person wronged. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [27]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> With respect, I disagree. In my view, Abella J.A.'s analysis does 
    not assist Dr.&nbsp;Harvey. On the contrary, it underscores a significant 
    flaw in his argument.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [28]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Unlike the discoverability rule, with which Abella J.A. was concerned, 
    the common law doctrine of fraudulent concealment is not a rule of construction. 
    It is an equitable principle aimed at preventing a limitation period from 
    operating “as an instrument of injustice” (see <i>M. (K.), supra</i>, at para. 
    66). When applicable, it will “take a case out of the effect of statute of 
    limitation” and suspend the running of the limitation clock until such time 
    as the injured party can reasonably discover the cause of action<a
style='mso-footnote-id:ftn6' href="#_ftn6" name="_ftnref6" title=""><span
class=MsoFootnoteReference><span style='mso-special-character:footnote'> [6] </span></span></a><span
style="mso-spacerun: yes">  </span>(see <i>M. (K.) supra,</i> at paras. 65 and 
    66). Its underlying rationale is grounded in the well-established principle, 
    reiterated in <i>Goldin (Trustee of) v. Bennett and Co.</i> (2003), 65 O.R. 
    (3d) 691 at para. 35, that equity will not permit a statute to be used as 
    an instrument of fraud.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [29]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In other words, unlike the discoverability rule, the doctrine of fraudulent 
    concealment is not dependent upon the particular wording of the limitation 
    provision. When applied, there is no risk that the limitation provision will 
    be construed in a manner not intended by the legislature. Fraudulent concealment 
    is concerned with the operation of the provision, not its interpretation. 
    Stated succinctly, it is aimed at preventing unscrupulous defendants who stand 
    in a special relationship with the injured party from using a limitation provision 
    as an instrument of fraud. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [30]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Once the doctrine’s true purpose and underlying rationale are understood, 
    Dr.&nbsp;Harvey’s reliance on <i>Waschkowski</i> as “determinative” holds 
    little sway. Applying the doctrine of fraudulent concealment to s. 38(3) of 
    the Act will have no impact on the provision’s meaning; nor will it detract 
    from the policy considerations giving rise to the implementation of s. 38 
    (unless the legislature contemplated the use of s. 38(3) as an instrument 
    of fraud). </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [31]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Harvey makes a secondary argument based upon Ontario’s new <i>Limitations 
    Act</i>, 2002, S.O. 2002, c. 24, Sched. B. Specifically, he points out that 
    s. 4 of that Act creates a basic two-year limitation period (to which the 
    discoverability rule applies) and that s. 15(2) creates an absolute limitation 
    period of fifteen years (regardless of discoverability but subject to suspension 
    where, among other things, there has been wilful concealment of material facts 
    outlined in s. 15(4)(c)(i)). Finally, he refers to s. 19(1) which specifically 
    exempts s. 38(3) of the <i>Trustee Act</i> from the provisions of the new 
    Act.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [32]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Considering the new Act as a whole and particularly s.&nbsp;15(4)(c) 
    that addresses matters akin to fraudulent concealment, Dr. Harvey submits 
    that by exempting s. 38(3) from the new Act, the legislature intended to immunize 
    it not only from the wilful concealment provisions of the new Act but also 
    from the common law doctrine of fraudulent concealment. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [33]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I would not give effect to that argument. In my view, s. 38(3) was 
    exempted from the new Act so that its common law status would be preserved 
    and it would remain immune from the discoverability rule. In other words, 
    the legislature intended that s.&nbsp;38(3) should continue to be governed 
    by common law principles. The doctrine of fraudulent concealment is one such 
    principle. Accordingly, I do not accept that the new <i>Limitations Act </i>assists 
    Dr. Harvey.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [34]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In conclusion, I am satisfied that the common law doctrine of fraudulent 
    concealment can be used to toll the two year limitation period prescribed 
    by s. 38(3) of the Act. The remaining question is whether the facts as pleaded 
    are capable of supporting it. That leads to the second issue on appeal.</p>
  <p class=MsoBodyText>Issue two: <span
style='mso-tab-count:1'>    </span>Can the facts as pleaded support a finding 
    of fraudulent concealment.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [35]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Dr. Harvey forcefully argues that the facts as pleaded are incapable 
    of supporting a finding of fraudulent concealment. Specifically, he submits 
    that he cannot be said to have concealed a fact of which the Giroux family 
    (and particularly Mrs. Giroux) was already aware when the limitation date 
    expired on September 28, 2001, two years after Mr.&nbsp;Giroux’s death. Prior 
    to that date, Dr. Hill’s letter of August 28, 2001, (in which he relayed Dr. 
    Harvey’s response to Gary Giroux’s queries) was the only possible source upon 
    which a finding of fraudulent concealment could be made. Accepting that in 
    that letter Dr. Harvey falsely represented that he had spoken to Mr. Giroux 
    about the nature of his illness and the need for radical treatment, on the 
    facts as pleaded, Mrs. Giroux was not deceived by those misrepresentations. 
    On the contrary, as indicated in paragraph 23 of the amended statement of 
    claim (reproduced below), by her own admission, she knew them to be false:</p>
  <p class=headingQUOTE>23.<span style="mso-spacerun:
yes">  </span>The Giroux family and Mrs. Giroux in particular, were shocked and 
    confused by Dr. Harvey’s representations. <i>Mrs.&nbsp;Giroux had accompanied 
    Mr. Giroux on every consultation and treatment: at no time did Dr. Harvey 
    ever discuss the possibility or need for radical treatment</i>. As a result, 
    upon receiving Dr. Hill’s letter, the plaintiffs requested that Dr. Hill meet 
    with them to discuss the matter further (emphasis added).</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [36]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In view of Mrs. Giroux’s admission, Dr. Harvey contends that Mr.&nbsp;Giroux’s 
    estate cannot now maintain that the false representations in the August 28, 
    2001 letter were responsible for concealing the existence of a cause of action 
    against him. He points to Gary Giroux’s letter to Dr. Hill and submits that 
    as early as July 2001, the estate knew that it had a cause of action against 
    him. He further submits that his false response did not deceive the estate 
    into thinking otherwise because at worst, it amounted to a denial of negligence 
    based on information which the family knew to be false. Thereafter, the steps 
    taken by the estate were not taken because the estate believed, on reasonable 
    grounds, that it may well not have a cause of action against him. Rather, 
    the estate proceeded as it did in order to ensure that it had an airtight 
    case against him before commencing its action. In such circumstances, even 
    if the discoverability rule applied (which it does not), it would not assist 
    the estate (see <i>Morton v. Cowan </i>(2003), 66 O.R. (3d) 321 (C.A.) at 
    para. 23.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [37]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> With respect, while I view the case as a close one, I am not persuaded 
    that Dr.&nbsp;Harvey’s argument should prevail at this stage. In rejecting 
    it, I do not suggest that the inferences which he seeks to draw from the pleadings 
    are not feasible. At the end of the day, they may be borne out. But we are 
    not there yet. This matter is at the pleading stage. The motion brought by 
    Dr. Harvey under Rule 21.01(1) requires that reasonable inferences of fact 
    be resolved in favour of the estate.<span style="mso-spacerun: yes">  </span>Viewed 
    that way, it is not plain and obvious to me that the limitation defence raised 
    by Dr. Harvey will inevitably succeed.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [38]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Taking the facts as pleaded at their highest, I believe that it would 
    be open for a trier of fact to find that as of August 28, 2001, Dr. Harvey 
    was in a special relationship with the Giroux family, that he attempted to 
    fraudulently conceal from them his failure to diagnose and properly treat 
    Mr. Giroux’s illness<a style='mso-footnote-id:ftn7' href="#_ftn7"
name="_ftnref7" title=""><span class=MsoFootnoteReference><span
style='mso-special-character:footnote'> [7] </span></span></a>, that his duplicity 
    was unconscionable in the circumstances and that it led the family to believe, 
    on reasonable grounds, that the estate might well not have a cause of action 
    against him – a belief that persisted until March 2003 when the College of 
    Physicians and Surgeons put it to rest.</p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [39]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Combined, those findings add to up to fraudulent concealment. In so 
    concluding, I have not ignored Mrs. Giroux’s assertion in paragraph 23 of 
    the amended claim that she attended with her husband on every visit to Dr. 
    Harvey and that at no time did Dr. Harvey prescribe radical treatment. While 
    that assertion is troubling, I am nonetheless of the view that on the facts 
    as pleaded, it would be open for a trier of fact to find that as a direct 
    result of Dr. Harvey’s duplicity in August 2001, the estate went from thinking 
    that it likely had a cause of action against him to thinking that it might 
    well not. In that regard, Dr.&nbsp;Harvey’s ploy was simple but potentially 
    very effective. It was designed to throw the estate off track by pitting his 
    credibility and reliability as a doctor and specialist in urology against 
    that of an elderly, distraught, grieving widow who had recently undergone 
    a very stressful period in her life. </p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [40]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Viewed that way, Dr. Harvey’s position that “the estate knew all along 
    that he was lying” loses much of its force and in my view, it leaves the door 
    open to a finding of fraudulent concealment. Accordingly, I would not give 
    effect to Dr. Harvey’s second ground of appeal.</p>
  <p class=MsoHeader><b>CONCLUSION</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [41]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Lederman J. was correct in holding that the common law doctrine of 
    fraudulent concealment can be used to toll the limitation period prescribed 
    by s. 38(3) of the Act.<span style="mso-spacerun: yes">  </span>He was also 
    correct in holding that the facts as pleaded are capable of supporting a finding 
    of fraudulent concealment.<span style="mso-spacerun: yes">  </span>Accordingly, 
    I would dismiss the appeal. </p>
  <p class=MsoHeader><b>COSTS</b></p>
  <p class=headingNUMBER align=left style='text-align:left;
line-height:normal'> [42]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The respondents are entitled to their costs of the appeal. If the 
    parties cannot agree, they may submit brief submissions to the court (not 
    to exceed three pages double-spaced) within ten days of the date of release 
    of these reasons.</p>
  <p class=MsoNormal style='text-align:justify'>Signed:<span
style='mso-tab-count:1'>           </span>“”M.J. Moldaver J.A.”</p>
  <p class=MsoNormal style='text-align:justify'><span
style='mso-tab-count:2'>                        </span>“I agree Marc Rosenberg 
    J.A.”</p>
  <p class=MsoNormal style='text-align:justify'><span
style='mso-tab-count:2'>                        </span>“I agree Janet Simmons 
    J.A.”</p>
  <p class=MsoBodyText style='text-align:justify'>Released: “MR” January 27, 2005</p>
</div>
<div style='mso-element:footnote-list'> <br clear=all>
  <hr align=left size=1 width="33%">
  <div style='mso-element:footnote' id=ftn1> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn1' href="#_ftnref1"
name="_ftn1" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [1] </span></span></a><span
style="mso-spacerun: yes">   </span>R.R.O. 1990, Reg. 194.</p>
  </div>
  <div style='mso-element:footnote' id=ftn2> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn2' href="#_ftnref2"
name="_ftn2" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [2] </span></span></a><span
style="mso-spacerun: yes">   </span>R.S.O. 1990, c. T. 23.</p>
  </div>
  <div style='mso-element:footnote' id=ftn3> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn3' href="#_ftnref3"
name="_ftn3" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [3] </span></span></a><span
style="mso-spacerun: yes">   </span>The motion raised additional matters that 
      were adjourned to a date to be fixed by the scheduling court.</p>
  </div>
  <div style='mso-element:footnote' id=ftn4> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn4' href="#_ftnref4"
name="_ftn4" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [4] </span></span></a><span
style="mso-spacerun: yes">  </span>Over the objection of Dr. Harvey, Lederman 
      J. did not consider the contents of two letters of complaint written by 
      Mr. Giroux’s wife and his son to the College of Physicians and Surgeons 
      on April 19, 2002.<span style="mso-spacerun: yes">  </span>Although raised 
      as a ground of appeal, the appellant did not pursue the issue in oral argument. 
      Without deciding the matter, Lederman&nbsp;J.’s approach would appear to 
      be sound (see <i>M.F. v. Sutherland</i> (2000), 134 O.A.C. 117).</p>
  </div>
  <div style='mso-element:footnote' id=ftn5> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn5' href="#_ftnref5"
name="_ftn5" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [5] </span></span></a><span
style="mso-spacerun: yes">   </span>The amended statement of claim describes cystosopy 
      as a “procedure … that enables a urologist to directly view the inside of 
      the bladder and urethra …”.</p>
  </div>
  <div style='mso-element:footnote' id=ftn6> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn6' href="#_ftnref6"
name="_ftn6" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [6] </span></span></a><span
style="mso-spacerun: yes">   </span>On the facts of this case, it is unnecessary 
      to finally decide when, in cases of fraudulent concealment, the limitation 
      clock starts to run or, having started to run, when it stops and when it 
      starts up again. That said, I reject Dr. Harvey’s submission that fraudulent 
      concealment cannot stop the clock from running once it has started. As pointed 
      out <i>in M. (K), supra</i> at para. 64 fraudulent concealment <i>may involve 
      active concealment of a right of action after the action has arisen</i> 
      or, it may arise from the manner in which the act that gives rise to the 
      right of action is performed (emphasis added).</p>
  </div>
  <div style='mso-element:footnote' id=ftn7> 
    <p class=MsoFootnoteText><a style='mso-footnote-id:ftn7' href="#_ftnref7"
name="_ftn7" title=""><span class=MsoFootnoteReference><span style='mso-special-character:
footnote'> [7] </span></span></a><span
style="mso-spacerun: yes">  </span>Dr. Harvey’s conduct after August 28 can be 
      used to show that the misrepresentations in Dr. Hill’s letter of August 
      28, were known by him to be false and were deliberately designed to mislead 
      the family and to conceal his inappropriate treatment.<span style="mso-spacerun:
yes">  </span></p>
  </div>
</div>
</body>
</html>
